Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ENDO 2023A 'One-Stop Shop': New Guidance on Hormones and Aging The 40-page statement covers natural history, available therapies, clinical trial data, key points, and gaps in the research, and is described by one expert as a 'one-stop shop' for information.
Medscape Medical News, June 19, 2023
ENDO 2023BMI 'Vastly Underestimates' True Obesity Body mass index missed half of US adults with obesity identified by body fat percentage in DEXA scans, strengthening the case that obesity assessment must be based on more than BMI alone.
Medscape Medical News, June 17, 2023
ENDO 2023Big Trial Reassures on Heart Safety of Testosterone in Men 'Real data on something that we've been prescribing for decades,' is how one expert describes the results of the FDA-mandated TRAVERSE trial of testosterone gel versus placebo in men with hypogonadism.
New Guideline for In-Hospital Care of Diabetes Says Use CGMsPatients with diabetes or newly recognized hyperglycemia get admitted to every patient service in the hospital and their glycemic
management can have a major effect on their outcomes.
Medscape Medical News, Jun 22, 2022
Jury Still Out on Cardiovascular Safety of TestosteroneA meta-analysis may provide some reassurance of the short-term cardiovascular safety of testosterone therapy for male hypogonadism
until definitive 5-year TRAVERSE trial findings are available, expected in late 2022.
